Ordinary Rebalance | Medical Care Growth Index | Effective Date 3rd November 2022

In the ordinary rebalancing the following index composition will be implemented effective open 03.11.2022:

ADICET BIO INC
ADMA BIOLOGICS INC
AGILON HEALTH ORD
APPLIED DNA SCIENCES INC
ARBUTUS BIOPHARMA CORP
ATARA BIOTHERAPEUTICS INC
AVEO PHARMACEUTICALS INC
BEAM THERAPEUTICS INC
BIOCRYST PHARMACEUTICALS INC
CANO HEALTH INC
CHINOOK THERAPEUTICS INC
CUE BIOPHARMA INC
DYNAVAX TECHNOLOGIES CORP
EIGER BIOPHARMACEUTICALS INC
GERON CORP
GINKGO BIOWORKS HOLDINGS INC
HOMOLOGY MEDICINES INC
INOTIV INC
INTRA-CELLULAR THERAPIES INC
IRADIMED CORP
KEROS THERAPEUTICS INC
KINIKSA PHARMACEUTICALS-A
LANTHEUS HOLDINGS INC
LINEAGE CELL THERAPEUTICS INC
MEIRAGTX HOLDINGS PLC
MERSANA THERAPEUTICS INC
MIRATI THERAPEUTICS INC
ONCOCYTE CORP
OSCAR HEALTH INC
PARATEK PHARMACEUTICALS INC
PROCEPT BIOROBOTICS ORD
PROMETHEUS BIOSCIENCES INC
PROPHASE LABS INC
QUIDELORTHO CORPORATION
REVANCE THERAPEUTICS INC
RHYTHM PHARMACEUTICALS INC
RXRX.OQ
SEER INC
SENSUS HEALTHCARE INC
SHOCKWAVE MEDICAL INC
TG THERAPEUTICS INC
THE BEAUTY HEALTH COMPANY
UROGEN PHARMA LTD
XERIS BIOPHARMA HOLDINGS INC